On 6 Nov 2026, Shelter Pharma was priced at ₹47.00, or 9.1× trailing earnings, against an industry P/E of 28.7×, and the shares are 16% below their 52-week high. Sales and net profit grew 26% and 20% a year over 3 years, with ROCE of 16% and ROE of 15%. It carries very little debt. It is listed on an SME platform with a market cap of ₹79 Cr, ranked 125th of 154 Drug Manufacturers (Specialty & Generic) companies by market cap; the shares rose 18% over the past year.
- ₹47.00
- ₹47.00
- ₹47.00
- ₹48.99
- 12K
Health check
- ReturnsIn line
+18.1% over a year, better than 3 of 7 peers.
- Price tagCheaper
P/E 9.1 vs industry 28.7.
- GrowthStrong
Sales +26.5%, profit +20.1% a year over 3 years.
- ProfitabilityAverage
ROCE 15.9% vs peer median 17.9%.
- Balance sheetStretched
Practically debt-free, Piotroski 3 of 9.
- Red flags1 to check
Quarterly profit down 11.1% on a year ago.
Small cap
Defensive
Key metrics
- Market cap
- ₹79 Cr
- Small cap
- P/E
- 9.1
- Industry 28.7
- Price to book
- 1.02
- Peers 4.99
- Dividend yield
- 0.00%
- ROE
- 15.1%
- Peers 14.7%
- ROCE
- 15.9%
- Peers 17.9%
- Debt to equity
- 0.01
- Debt ₹0.80 Cr
- EPS (TTM)
- ₹5.16
- OPM (TTM)
- 15.7%
- Net margin 12.3%
- Sales growth
- +49.8%
- Latest quarter vs a year ago
- Profit growth
- −11.1%
- Latest quarter vs a year ago
- Price to sales
- 1.08
- EV/EBITDA 6.1
Strengths and risks
Strengths
- Practically debt-free.
- Quarterly sales up 49.8% on a year ago.
- P/E of 9.1 against an industry P/E of 28.7.
Risks to check
- Quarterly profit down 11.1% on a year ago.
About Shelter Pharma
Shelter Pharma Limited manufactures and sells pharmaceutical products for human and veterinary healthcare businesses in India. The company offers tablets, liquids, ointments, syrups, capsules, and oil for human health care; and mineral mixture for veterinary health care. It also provides OTC and ethical products. The company sells its products through distribution network, as well as exports its products. Shelter Pharma Limited was founded in 1965 and is…
- Headquarters
- Ahmedabad
- Employees
- 51
- Sector
- Healthcare
- ISIN
- INE013V01011
- Website
- shelter.co.in
Price range
- Avg volume (3M)
- 64.9K
- 1-year return
- plus 18.1%
- From 52-week high
- minus 15.9%
Peers · Drug Manufacturers - Specialty & Generic
| Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMASun Pharmaceutical Industries | 1,860.00 | plus 1.69% | 4,46,276 | 40.7 | 4.99 | 17.9% | 13.1% | 28.2% | 10.4% | 10.6% | 0.86% | plus 8.2% |
| DIVISLABDivi's Laboratories | 10,320.50 | plus 1.78% | 2,73,977 | 93.6 | 16.35 | 19.0% | 16.2% | 34.9% | 11.0% | 12.1% | 0.29% | plus 49.0% |
| TORNTPHARMTorrent Pharmaceuticals | 4,750.00 | plus 0.85% | 1,80,675 | 80.2 | 9.83 | 9.1% | 15.7% | 33.7% | 13.3% | 20.2% | 0.80% | plus 31.7% |
| LAURUSLABSLaurus Labs | 2,340.00 | minus 0.26% | 1,26,433 | 94.4 | 20.86 | 19.5% | 24.0% | 30.4% | 3.8% | 4.0% | 0.09% | plus 138.6% |
| ZYDUSLIFEZydus Lifesciences | 1,197.90 | plus 0.41% | 1,19,491 | 28.6 | 4.29 | 19.0% | 14.7% | 26.2% | 16.5% | 37.0% | 0.08% | plus 22.8% |
| DRREDDYDr. Reddy's Laboratories | 1,373.00 | plus 0.51% | 1,14,462 | 40.9 | 2.96 | 14.2% | 7.3% | 15.9% | 11.0% | −1.7% | 0.58% | plus 13.8% |
| CIPLACipla | 1,411.00 | plus 0.49% | 1,13,993 | 39.4 | 3.22 | 14.9% | 8.3% | 17.3% | 7.2% | 11.5% | 0.92% | minus 6.6% |
| SHELTERShelter Pharma | 47.00 | minus 4.06% | 79 | 9.1 | 1.02 | 15.9% | 15.1% | 15.7% | 26.5% | 20.1% | 0.00% | plus 18.1% |
| Median of 7 peers | – | 0.51% | 1,26,433 | 40.9 | 4.99 | 17.9% | 14.7% | 28.2% | 11.0% | 11.5% | 0.58% | 22.8% |
Quarterly results
This company doesn’t report these figures in a format we can read yet.
Profit & loss
- Sales CAGR 3Y
- +26.5%
- Profit CAGR 3Y
- +20.1%
- ROE
- 15.1%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 36.2 | 40 | 50.7 | 73.1 | |
| – | +10.7% | +26.6% | +44.4% | |
| 27.8 | 30.9 | 40.3 | 60 | |
| 8.4 | 9.1 | 10.4 | 13.1 | |
| 23.2% | 22.7% | 20.5% | 17.9% | |
| −0 | −0 | −0.1 | −0.1 | |
| 0 | 0.2 | 0 | 0.1 | |
| 0.2 | 0.2 | 0.3 | 0.4 | |
| −1.2 | −0.3 | −0.3 | −0.3 | |
| 7 | 8.3 | 9.7 | 12.2 | |
| 25.4% | 25.1% | 25.2% | 26.2% | |
| 5.2 | 6.2 | 7.2 | 9 | |
| – | +19.1% | +16.7% | +24.7% | |
| 4.49 | 5.36 | 6.26 | – |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 7.7 | 11.6 | 11.6 | 16.6 | |
| 6.8 | 24.3 | 31.2 | 60 | |
| 1.8 | 0.6 | 1 | 0.8 | |
| 5.1 | 1.5 | 4.6 | 6.8 | |
| 21.4 | 37.9 | 48.3 | 84.2 | |
| 1.8 | 3.6 | 6 | 6.7 | |
| – | 0.6 | 3.2 | −0 | |
| 0 | 0 | 0 | 0 | |
| 0.4 | 5 | 3.4 | 1.1 | |
| 19.2 | 28.7 | 35.8 | 76.5 | |
| 21.4 | 37.9 | 48.3 | 84.2 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| −1 | −2 | 5.4 | −12.5 | |
| 0.1 | −4.5 | −7.1 | −14.6 | |
| 0.3 | 11 | 0.1 | 24.7 | |
| −0.6 | 4.5 | −1.6 | −2.3 | |
| −0 | −0.9 | −2.7 | −1.6 | |
| −1 | −2.8 | 2.8 | −14.1 | |
| – | – | −0.4 | −0.4 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.